Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 200835
Company: WATSON LABS INC

Products on ANDA 200835

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BUPROPION HYDROBROMIDE	BUPROPION HYDROBROMIDE	174MG	TABLET, EXTENDED RELEASE; ORAL	None (Tentative Approval)	None	No	No
BUPROPION HYDROBROMIDE	BUPROPION HYDROBROMIDE	522MG	TABLET, EXTENDED RELEASE; ORAL	None (Tentative Approval)	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 200835

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/13/2013	ORIG-1	Tentative Approval	Not Applicable			Label is not available on this site.